Table 3

Secondary investigation using adjusted OR (aOR) and 95% CI for visual outcomes based on type of cerebral injury, relative to no cerebral injury

Possible risk factorBlindness
n/N (%)
aOR* (95% CI)P value
Reference group: no cerebral injury80/15 586 (0.5)1.0
a. Ventricular size enlarged (with or without concurrent/prior blood)33/2141 (1.5)2.23 (1.49 to 3.33)<0.0001
b. Blood/echodensity in parenchyma with or without midline shift†0/200 (0)N/A
c. PVL15/294 (5.1)8.94 (4.60 to 17.4)<0.0001
d. Combination of ≥2 above cerebral injury criteria45/1149 (3.9)5.58 (3.33 to 9.36)<0.0001
e. Any of criteria A–D with shunt for hydrocephalus40/476 (8.4)12.7 (8.86 to 18.2)<0.0001
  • *The adjusted ORs and p values are from a logistic regression model using GEE; the model adjusted for sex, birth weight, multiple birth, maternal race, type of cerebral injury (none; ventricular size enlarged only; PVL only; two or more of the following: ventricular size enlarged, PVL, blood/echodensity in the parenchyma; one of the above with shunt for hydrocephalus), severe ROP and centre as a cluster effect. The model does not include an interaction term between type of cerebral injury and severe ROP because we also assessed this interaction in a separate logistic regression model and found no significant interaction (p=0.15).

  • †Infants with blood/echodensity in parenchyma (only) were excluded from the regression since none of these infants had the outcome of blindness.

  • GEE, generalised estimating equation; PVL, periventricular leukomalacia; ROP, retinopathy of prematurity.